BG61592B1 - Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му - Google Patents

Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му Download PDF

Info

Publication number
BG61592B1
BG61592B1 BG99252A BG9925294A BG61592B1 BG 61592 B1 BG61592 B1 BG 61592B1 BG 99252 A BG99252 A BG 99252A BG 9925294 A BG9925294 A BG 9925294A BG 61592 B1 BG61592 B1 BG 61592B1
Authority
BG
Bulgaria
Prior art keywords
weight
layer
core
active agent
tablet
Prior art date
Application number
BG99252A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99252A (en
Inventor
Pal Fekete
Geb. Ignacz Maria Kiraly
Gabor Sipos
Geb. Hoffmann Zsuzsanna Jambor
Gyoergy Ujfalussy
Geb. Hernyes Magdolna Gora
Imre Klebovich
Sandor Drabant
Attila Mandi
Geb. Szabo Gizella Kiss
Erzsebet Barczay
Maria Kriszitian
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of BG99252A publication Critical patent/BG99252A/bg
Publication of BG61592B1 publication Critical patent/BG61592B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
BG99252A 1993-12-09 1994-12-09 Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му BG61592B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9303504A HU213407B (en) 1993-12-09 1993-12-09 Process for producing tablet with diffusive-osmotic release

Publications (2)

Publication Number Publication Date
BG99252A BG99252A (en) 1995-09-29
BG61592B1 true BG61592B1 (bg) 1998-01-30

Family

ID=10984230

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99252A BG61592B1 (bg) 1993-12-09 1994-12-09 Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му

Country Status (21)

Country Link
US (1) US5543155A (ja)
EP (1) EP0662321B1 (ja)
JP (1) JPH07277957A (ja)
KR (1) KR950016714A (ja)
AT (1) ATE185693T1 (ja)
BE (1) BE1009867A3 (ja)
BG (1) BG61592B1 (ja)
CA (1) CA2137426A1 (ja)
CZ (1) CZ288014B6 (ja)
DE (1) DE69421263T2 (ja)
ES (1) ES2114423B1 (ja)
FR (1) FR2713484B1 (ja)
GR (1) GR1002349B (ja)
HR (1) HRP940979A2 (ja)
HU (1) HU213407B (ja)
IT (1) IT1271122B (ja)
PL (1) PL306181A1 (ja)
RU (1) RU2133605C1 (ja)
SK (1) SK279735B6 (ja)
UA (1) UA34458C2 (ja)
YU (1) YU71894A (ja)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
CN1135265C (zh) * 1996-04-12 2004-01-21 诺沃奇梅兹有限公司 含酶颗粒及其生产方法
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
KR100522248B1 (ko) * 1997-05-29 2006-02-01 동아제약주식회사 이중제어방출막구조의경구서방성제제및그제조방법
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
US6416786B1 (en) 1998-12-11 2002-07-09 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
BR0016707A (pt) 1999-12-23 2002-09-03 Pfizer Prod Inc Forma de dosagem de droga em camadas acionada por hidrogel
EE200200361A (et) * 1999-12-23 2003-10-15 Pfizer Products Inc. Hüdrogeeli-juhitav ravimi doseerimise vahend
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
JP2003521507A (ja) 2000-02-04 2003-07-15 ディポメド，インコーポレイティド ゼロ次薬物放出に接近するシェル−コア剤形
US6268368B1 (en) * 2000-03-01 2001-07-31 American Pharmaceuticals International Anionic exchange polymer complexes of buspirone
US6399101B1 (en) 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20040062787A1 (en) * 2001-12-17 2004-04-01 Daley William Lionel Therapeutic combination of amlodipineand benazepril/benazeprilat
US6419903B1 (en) * 2001-08-20 2002-07-16 Colgate Palmolive Company Breath freshening film
US8329217B2 (en) * 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20030185882A1 (en) 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US6645526B2 (en) 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
WO2003059328A1 (en) 2002-01-15 2003-07-24 Ucb Farchim, S.A. Formulations
TW200302748A (en) * 2002-02-01 2003-08-16 Pfizer Prod Inc Osmotic delivery system
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
JP3887588B2 (ja) * 2002-08-30 2007-02-28 株式会社リガク Ｘ線回折による応力測定法
AR045330A1 (es) * 2003-08-07 2005-10-26 Sb Pharmco Inc Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla
CA2571554A1 (en) * 2004-06-28 2006-01-19 Alza Corporation A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
GB2421431B (en) * 2004-12-24 2007-10-10 Aquasol Ltd Dosing systems
US8431156B2 (en) * 2005-02-22 2013-04-30 Sun Pharma Advanced Research Company Ltd. Pharmaceutical composition
EP1912622A2 (en) * 2005-08-04 2008-04-23 Alza Corporation Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
US20070128280A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US20070128282A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US20070128281A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US7714201B2 (en) * 2006-12-22 2010-05-11 Monsanto Technology Llc Cotton variety 781000G
US7419684B2 (en) * 2006-12-22 2008-09-02 Reliant Pharmaceuticals, Inc. System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same
US20110142905A1 (en) * 2008-08-14 2011-06-16 Bioneer A/S Coated tablets with remaining degradation surface over the time
AR076907A1 (es) * 2009-05-13 2011-07-20 Wyeth Llc Composiciones con liberacion rapida de farmaco
US9861585B2 (en) 2012-10-16 2018-01-09 Sun Pharmaceutical Industries Limited Osmotic floating tablets
CN104721051B (zh) * 2014-12-17 2018-03-20 镇江杏林医疗科技有限公司 理疗贴及其柱形膏的制作方法
AU2016272089B2 (en) 2015-06-03 2021-02-18 Triastek, Inc. Dosage forms and use thereof
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
DE3438291A1 (de) * 1984-10-19 1986-04-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine

Also Published As

Publication number Publication date
BG99252A (en) 1995-09-29
FR2713484B1 (fr) 1997-12-12
IT1271122B (it) 1997-05-26
JPH07277957A (ja) 1995-10-24
RU2133605C1 (ru) 1999-07-27
CZ309994A3 (en) 1995-07-12
US5543155A (en) 1996-08-06
RU94043798A (ru) 1996-11-10
PL306181A1 (en) 1995-06-12
DE69421263D1 (de) 1999-11-25
UA34458C2 (uk) 2001-03-15
DE69421263T2 (de) 2000-05-11
ITMI942484A1 (it) 1996-06-09
YU71894A (sh) 1997-03-07
ITMI942484A0 (it) 1994-12-09
CA2137426A1 (en) 1995-06-10
SK279735B6 (sk) 1999-03-12
ES2114423A1 (es) 1998-05-16
CZ288014B6 (cs) 2001-04-11
FR2713484A1 (fr) 1995-06-16
HU9303504D0 (en) 1994-04-28
HU213407B (en) 1997-06-30
SK152494A3 (en) 1995-07-11
EP0662321B1 (en) 1999-10-20
HRP940979A2 (en) 1997-02-28
GR1002349B (el) 1996-05-29
ES2114423B1 (es) 1999-07-01
HUT69397A (en) 1995-09-28
KR950016714A (ko) 1995-07-20
EP0662321A1 (en) 1995-07-12
BE1009867A3 (fr) 1997-10-07
ATE185693T1 (de) 1999-11-15

Similar Documents

Publication Publication Date Title
BG61592B1 (bg) Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му
US6537573B2 (en) Combination dosage form comprising cetirizine and pseudoephedrine
CN100402021C (zh) 包含3-(3-二甲基氨基-1-乙基-2-甲基-丙基)苯酚并能提供活性成分的延迟释放的药物
KR100205276B1 (ko) 서방성 정제
RU2179017C2 (ru) Фармацевтическая композиция для контролируемого высвобождения активных веществ (варианты) и способ ее получения (варианты)
KR101087464B1 (ko) 부프로피온 히드로클로라이드의 개질 방출형 정제
CA2470747C (en) Extended release pharmaceutical tablet of metformin
MX2010008861A (es) Tableta oral de liberacion controlada con efecto de liberacion masiva reducido.
BG107372A (bg) Препарати със забавено действие на хинолонови антибиотици и метод за получаването им
ZA200500834B (en) Oral dosage form comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
IE69174B1 (en) A system for the controlled release of active agents and a process for its preparation
CA2554874A1 (en) Methods of reducing alcohol-induced dose dumping for hydromorphone sustained release oral dosage forms
EP2521537A2 (en) Pharmaceutical composition for modified delivery of actives